Results of twin-studies have suggested that developing chemicals to slow down an enzyme that provides multi-resistance to antibiotics may be the key to reverse antibiotic resistance. Antibiotic resistance is slowly gaining momentum as a global crisis. It occurs when bacteria change in a way that reduces the effectiveness of drugs, chemicals, or other agents designed to cure or prevent infections.
As it becomes increasingly prevalent, it also threatens to undermine healthcare systems across the globe. Beta-lactamases are enzymes produced by bacteria, that provide multi-resistance to beta-lactam antibiotics such as penicillins, Cephalosporins, cephamycins, and carbapenems, although carbapenems are relatively resistant to beta-lactamase. In the first study, researchers from University of Bristol in the UK, defined the relative importance of two mechanisms associated with beta-lactam…
